S-1/A: Natures Miracle Holding Inc. Files Amendment No. 3 to Form S-1 Registration Statement for Public and Resale Offerings

Natures Miracle Holding Inc. is proceeding with a public offering of units and pre-funded units, along with a resale offering by certain selling stockholders, as detailed in their amended S-1 filing.

Summary

• Natures Miracle Holding Inc. filed Amendment No. 3 to its Form S-1 registration statement with the SEC on October 31, 2024.
• The registration statement covers a public offering of up to 29,032,258 Units, each consisting of one share of common stock, one Series A Warrant, and one Series B Warrant.
• It also includes 29,032,258 Pre-funded Units, each consisting of one Pre-Funded Warrant, one Series A Warrant, and one Series B Warrant.
• Additionally, the registration statement covers a resale offering by certain selling stockholders of 3,317,400 shares of common stock, including 2,924,150 outstanding shares and 393,250 shares issuable upon exercise of outstanding warrants.
• The assumed public offering price is $0.155 per Unit, based on the closing price of the company's common stock on October 24, 2024.
• The company intends to use the proceeds from the offering for general corporate purposes, including working capital and investments.
• The Series A Warrants have an exercise price of $0.155 per share and expire 5 years after Warrant Stockholder Approval.
• The Series B Warrants have an exercise price of $0.0001 per share and expire 2 years after Warrant Stockholder Approval.
• The exercise price and number of shares issuable under the Series A Warrants are subject to adjustment, and the number of shares issuable under the Series B Warrants will be determined following the 10th trading day after Warrant Stockholder Approval.
• The maximum number of shares of common stock underlying the Series A Warrants would be approximately 145,161,290, and the maximum number of shares underlying the Series B Warrants would be approximately 116,129,032.
• The Warrants will be exercisable only upon receipt of Warrant Stockholder Approval.
• The selling stockholders in the resale offering may not commence the resale of their shares pursuant to the Resale Prospectus until after the primary offering closes.
• The company's common stock is listed on The Nasdaq Global Market under the symbol NMHI.
• The company received a delisting notice from Nasdaq on October 24, 2024, due to failure to regain compliance with listing requirements.
• The company has requested a hearing to appeal the delisting determination, which will be held on December 17, 2024.

Sentiment

Score: 4

Explanation: The sentiment is slightly negative due to the delisting notice and the need for a capital raise, but the company is taking steps to address the issues.

Positives

• The company is raising capital for general corporate purposes, including working capital and investments.
• The company has requested a hearing to appeal the delisting determination, which stays the suspension of the company's securities.

Negatives

• The company received a delisting notice from Nasdaq on October 24, 2024, due to failure to regain compliance with listing requirements.
• There is no established trading market for the Units, Pre-Funded Units, Warrants or Pre-Funded Warrants.

Risks

• The Warrants will be exercisable only upon receipt of Warrant Stockholder Approval.
• The public offering price for the securities in this offering will be determined at the time of pricing, and may be at a discount to the current market price at the time.
• Investing in our securities involves a high degree of risk.
• We may not be able to continue to satisfy listing requirements of Nasdaq to maintain a listing of our common stock.

Future Outlook

The company intends to use the net proceeds from the offering for general corporate purposes, including working capital and investments. The company will present a plan to regain compliance with Nasdaq continued listing requirements at the hearing on December 17, 2024.

Industry Context

The announcement reflects the ongoing capital-raising activities and challenges faced by smaller companies in the current market environment, particularly those in emerging sectors like agriculture technology. The delisting notice highlights the importance of maintaining compliance with exchange listing requirements, which can impact investor confidence and access to capital.

Comparison to Industry Standards

• It's difficult to compare Natures Miracle directly to industry standards without knowing their specific financial metrics (revenue, profit, etc.) and business model in detail.
• However, we can make some general observations:
• Capital Raising: Many small-cap companies in emerging industries rely on public offerings to raise capital.
• The terms of the offering (unit price, warrant structure) are fairly typical for companies in this situation.
• Nasdaq Compliance: Maintaining Nasdaq listing is crucial for credibility and access to capital.
• Delisting notices are a concern, and companies often undertake measures like reverse stock splits or demonstrating improved financials to regain compliance.
• Comparable Companies: Companies like Agrify (before its merger termination with Natures Miracle) and urban-gro operate in similar spaces.
• Comparing their financial performance and market capitalization to Natures Miracle could provide some context, but a detailed analysis would be needed.

Stakeholder Impact

• Shareholders may experience dilution as a result of this and future equity offerings.
• The company's stock price may fluctuate significantly.
• If the company is delisted from Nasdaq, it could negatively affect the liquidity and market price of the common stock.

Next Steps

• The company will present a plan to regain compliance with Nasdaq continued listing requirements at the hearing on December 17, 2024.
• The company intends to implement a reverse split within a ratio ranging from 1:2 to 1:30, as determined by the Board of Directors in its sole discretion, to regain compliance with the minimum bid price requirement.

Key Dates

Keywords

public offering, resale offering, units, pre-funded units, warrants, common stock, natures miracle, registration statement, delisting, nasdaq